Genfit S.A. (GNFT)
NASDAQ: GNFT · IEX Real-Time Price · USD
3.520
+0.120 (3.53%)
May 2, 2024, 1:09 PM EDT - Market open
Genfit Revenue
In the year 2023, Genfit had annual revenue of $42.42M with 50.09% growth.
Revenue (ttm)
$42.42M
Revenue Growth
+50.09%
P/S Ratio
4.03
Revenue / Employee
$266,778
Employees
159
Market Cap
173.41M USD
Revenue Chart
* The company reports in EUR currency but revenue data is shown in USD.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 42.42M | 14.16M | 50.09% |
Dec 31, 2022 | 28.26M | -68.99M | -70.94% |
Dec 31, 2021 | 97.25M | 87.79M | 927.89% |
Dec 31, 2020 | 9.46M | -36.56M | -79.44% |
Dec 31, 2019 | 46.02M | 37.41M | 434.30% |
Dec 31, 2018 | 8.61M | 386.26K | 4.69% |
Dec 31, 2017 | 8.23M | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Inogen | 315.66M |
American Well | 259.05M |
Butterfly Network | 65.90M |
Compugen | 33.46M |
Inventiva | 25.74M |
Capricor Therapeutics | 25.18M |
bluebird bio | 21.73M |
GNFT News
- 6 days ago - GENFIT: Publication of the 2024 Extra-Financial Performance Report (fiscal year 2023) - GlobeNewsWire
- 16 days ago - GENFIT Annual Combined General Meeting of May 22, 2024 — Availability of Preparatory Documents - GlobeNewsWire
- 27 days ago - GENFIT Announces Publication of the 2023 Universal Registration Document and the 2023 Annual Report on Form 20-F - GlobeNewsWire
- 27 days ago - GENFIT Reports Full-Year 2023 Financial Results and Provides Corporate Update - GlobeNewsWire
- 2 months ago - GENFIT Announces Revenues and Cash Position as of December 31, 2023 - GlobeNewsWire
- 3 months ago - GENFIT Announces 2024 Financial Calendar - GlobeNewsWire
- 3 months ago - GENFIT: Half-Year Report of Liquidity Contract with Crédit Industriel et Commercial - GlobeNewsWire
- 5 months ago - GENFIT Updates 2024 Outlook Following Acceptance of Elafibranor Filings in Primary Biliary Cholangitis (PBC) - GlobeNewsWire